dm+d
327397006
Articles
Trastuzumab: informing intrathecal risk assessment
11 August 2022
Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administrationRefrigerated Storage
Enhertu
Daiichi Sankyo UK LtdDaiichi Sankyo UK Ltd
Enhertu
100mg powder for concentrate for solution for infusion
Contact Daiichi Sankyo UK Ltd in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk
12 November 2021
London MI Service